Central to this study is the protein RAD52, which has long been identified as a key player in the repair of DNA in cancer cells deficient in BRCA1 or BRCA2. These mutations render typical repair mechanisms inactive, yet RAD52 enables cellular survival by facilitating DNA single-strand annealing (SSA), a process by which broken DNA strands are rejoined. Understanding and ultimately blocking RAD52’s repair functions holds promise in selectively targeting cancer cells that have become resistant to conventional therapies.

Historically, capturing the intricate steps of RAD52’s repair activities has eluded the scientific community due to the fleeting nature of these molecular processes and the complexity of human proteins. To circumvent this challenge, the research team turned to Mgm101, an ancient homolog of RAD52 found in yeast mitochondria. This model system allowed for a more accessible observation of DNA binding and repair activities intrinsic to this protein family, revealing insights that are directly translatable to human biology.

Utilizing a combination of native mass spectrometry, mass photometry, and cutting-edge cryogenic electron microscopy (cryo-EM), the team resolved the architecture and dynamic states of Mgm101 throughout the DNA repair process. Mass photometry illuminated the assembly of Mgm101 monomers into a highly specific 19-mer ring complex, which acts as a molecular scaffold facilitating the coordinated annealing of complementary DNA strands. This precise ring formation is integral to the protein’s function in unwinding and aligning DNA segments for efficient rejoining.

Cryo-EM imaging, executed under conditions preserving the native structural fidelity of protein-DNA complexes, captured multiple distinct phases of the annealing process. These included the initial substrate state—where a single DNA strand is bound to the protein complex—the duplex intermediate where the second DNA strand engages and begins annealing, and the final product, a classic double-stranded DNA helix released from the protein scaffold. Notably, the duplex intermediate conformation represents a previously undocumented state, where the DNA bases are exposed and extended, optimizing their accessibility for sequence scanning and alignment.

This structural elucidation addresses a longstanding question in the DNA repair field: whether single-strand annealing involves one or multiple protein rings. The data compellingly demonstrate that a single 19-mer protein ring is sufficient to mediate the entire annealing reaction, implying a conserved cis mechanism wherein the repair occurs within the confines of one molecular complex. This discovery refines our understanding of SSA mechanics and confers new perspectives on the regulation of DNA repair.

Furthermore, the research bridges an important conceptual gap in the functional parallels between RAD52 and its yeast counterpart Mgm101. While prior structural studies have focused on RAD52 bound to single-stranded DNA, the current investigation reveals critical intermediate states that have proven elusive—particularly the duplex intermediate—thus enriching the framework for drug development aimed at obstructing RAD52-mediated repair in BRCA-mutated cancers.

The collaboration featured a multidisciplinary approach, integrating expertise from Ohio State University’s prominent cryo-EM facilities and Georgia Institute of Technology’s innovative mass spectrometry and photometry platforms. The synergy between these technological approaches enabled a comprehensive, high-resolution depiction of the protein-DNA interactions essential to single-strand DNA annealing.

Looking ahead, the researchers plan to extend their studies directly to human RAD52, with a focus on replicating these captured states, especially the duplex intermediate. Integrating mass spectrometry techniques will further unravel how DNA strands bind to the protein complex during each repair phase, providing refined molecular targets for future anti-cancer drug design.

This pioneering work not only elevates our molecular understanding of DNA repair but also invigorates the prospect of pharmacological interventions. By honing in on RAD52’s unique structural phases, scientists can potentially develop inhibitors that selectively eradicate cancer cells reliant on this alternate repair pathway, thereby addressing treatment resistance in BRCA mutation-associated malignancies.

The study was graciously funded by the U.S. National Science Foundation and the National Institutes of Health, underscoring the national commitment to pioneering cancer research. Technical support included data collection at Ohio State’s Center for Electron Microscopy and Analysis and computational processing at the Ohio Supercomputer Center, reflecting a high-caliber convergence of institutional resources.

Collectively, these findings represent a critical step toward decoding the complex choreography of DNA repair in cancer cells, and they may well catalyze the design of novel therapeutics capable of exploiting the vulnerabilities introduced by mutated BRCA genes.

Subject of Research:
The molecular mechanism of single-strand DNA annealing facilitated by the RAD52 protein family, using structural and biophysical analysis of its yeast homolog Mgm101.

Article Title:
Mechanism of single-strand annealing from native mass spectrometry and cryo-EM structures of RAD52 homolog Mgm101

News Publication Date:
April 27, 2026

Web References:
http://dx.doi.org/10.1093/nar/gkag320

Keywords:
RAD52, Mgm101, DNA repair, single-strand annealing, cryo-electron microscopy, mass spectrometry, BRCA mutations, cancer biology, DNA strand repair mechanism, protein-DNA interactions.

Replication forks are dynamic DNA structures arising during genome duplication where the DNA double helix unwinds, allowing enzymatic machinery to faithfully copy genetic information. However, when replication encounters obstacles such as endogenous lesions or replication stress, the replication fork can stall or collapse, resulting in single-ended double-strand breaks that pose a significant threat to genomic integrity. Traditionally, the cell was thought to predominantly employ BIR to mend such damage. BIR leverages an intact homologous DNA template to restart replication, thereby preserving genetic fidelity but operating at a relatively slow pace.

Contrasting with BIR, MMEJ is a more rapid, though error-prone, repair mechanism that aligns short homologous DNA sequences—microhomologies—to join broken DNA ends. Historically, MMEJ has been considered a backup mechanism, primarily mediating repair of double-ended breaks independent of replication. This new research overturns that paradigm by revealing that MMEJ, catalyzed by Polθ, is directly engaged at broken replication forks. Employing CRISPR nickase technology to precisely induce replication fork collapse and using sophisticated reporter systems alongside genome sequencing, the researchers identified unique mutational footprints inconsistent with canonical BIR but characteristic of fork-specific MMEJ.

These observations suggest that the MMEJ operating at replication forks—termed fork-MMEJ—differs mechanistically and functionally from its standard counterpart. Unlike canonical MMEJ, fork-MMEJ is initiated by the replication protein A (RPA), a single-stranded DNA-binding protein active during replication stress. This initiation results in asymmetric deletion patterns flanking the break site, creating a distinctive mutational signature frequently observed in various cancer genomes. Such error-prone repair may offer a double-edged sword: while compromising genome stability, it paradoxically confers tumors with resilience against lethal DNA damage, enabling continued proliferation under stress conditions.

Polθ’s central role in this process positions it as an even more compelling target for anticancer drug development than previously appreciated. Notably, tumors deficient in homologous recombination repair pathways, including those harboring BRCA1 or BRCA2 mutations, are especially reliant on Polθ-mediated MMEJ for survival. Inhibiting Polθ in these contexts disrupts the tumor cells’ ability to cope with replication-associated damage, selectively undermining their viability.

In a novel therapeutic insight, the study also highlights the interplay between fork-MMEJ and BIR regulated by the ATR kinase—a protein that senses DNA damage and orchestrates repair pathway choice. ATR suppresses fork-MMEJ, favoring the more accurate but slower BIR. Intriguingly, simultaneous inhibition of ATR and Polθ amplifies cancer cell death under replication stress conditions, with minimal adverse effects on normal cells. This synergy opens promising avenues for combination therapies harnessing existing ATR inhibitors alongside emerging Polθ inhibitors, potentially overcoming resistance mechanisms and improving clinical outcomes.

The profound implication of this research lies in reframing the timing and hierarchy of DNA repair mechanisms at replication forks. Whereas MMEJ was thought to function predominantly downstream or in backup capacities, it now appears integral to initial responses against replication-induced DNA breakage. This understanding could transform strategic drug targeting, emphasizing the disruption of Polθ activity at the earliest stages of DNA damage repair.

Looking forward, the Scripps Research team is expanding their investigation to elucidate additional protein components within the fork-MMEJ pathway. Each newly identified factor may represent a novel molecular target, broadening the landscape for therapeutic intervention. Moreover, they seek to deepen insights into ATR’s modulatory role, deciphering the molecular switches that balance repair pathway engagement and influence cell fate under replication stress.

This paradigm-shifting discovery not only advances fundamental knowledge of DNA damage responses in cancer biology but also redefines potential treatment strategies. By illuminating how cancer cells co-opt an error-prone yet expedient repair mechanism at replication forks, it opens doors to innovative therapies aimed at exploiting this vulnerability. The work underscores the criticality of targeting replication stress responses, a hallmark of cancer, to selectively eliminate tumor cells while sparing normal tissues.

As therapies evolve to incorporate precision targeting of DNA repair enzymes, understanding the nuanced differentiation between repair pathways becomes essential. Polθ’s newfound prominence reinforces the urgency of completing clinical development of inhibitors that can effectively disrupt the MMEJ process at replication forks. Combined with ATR inhibition approaches, such treatments promise a new frontier in cancer therapy, characterized by enhanced specificity and fewer side effects.

In summary, this compelling study marks a transformative advance in the field of cancer genomics and DNA repair. It challenges long-standing dogma, unveiling a previously underappreciated mechanism of fork-associated DNA repair mediated by Pol theta and MMEJ. This deeper mechanistic insight not only elucidates how tumors endure relentless replication stress but also provides a robust foundation for next-generation therapeutic strategies aimed at crippling cancer cells’ adaptive DNA repair capabilities.

Subject of Research: DNA repair mechanisms operative at broken replication forks in cancer cells, focusing on Pol theta–mediated microhomology-mediated end joining.

Article Title: Microhomology-mediated end joining acts directly on replication forks to repair single-ended double-strand breaks.

News Publication Date: 16-Mar-2026

Web References:
https://www.cell.com/molecular-cell/fulltext/S1097-2765(26)00130-9
http://dx.doi.org/10.1016/j.molcel.2026.02.016

References:
Li, S., Zhao, Y., Li, Y., Shah, S.B., Shi, Y., Nguyen, T., Bu, T-H., Loguercio, S., Sussman, J.H., Wang, Z., Chang, C-Y., Aladjem, M.I., Ray, A., Sasaki, T., Gilbert, D.M., Wang, H., Wu, X. (2026). Microhomology-mediated end joining acts directly on replication forks to repair single-ended double-strand breaks. Molecular Cell.

Image Credits: Scripps Research

Keywords: DNA damage response, replication fork collapse, Pol theta, microhomology-mediated end joining, break-induced replication, replication stress, DNA repair pathways, cancer therapeutics, ATR kinase, BRCA mutations, genome stability, replication-associated DNA breaks